Polyethylene glycol recombinant endostatin
Term · Oncology and biomedicine · MLC-T-ONC-016157
A formulation containing recombinant endostatin attached to polyethylene glycol (PEG), with potential anti-angiogenic and antineoplastic activities. Endostatin, a 20 kDa C-terminal proteolytic fragment of collagen XVIII, induces microvascular endothelial cell apoptosis and inhibits endothelial proliferation and angiogenesis, which may result in a reduction of tumor cell growth. Modification with PEG extends the circulation half-life of endostatin, improves stability and increases solubility in organic solvents.
| Identifier | MLC-T-ONC-016157 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | M2ES |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016157",
"term": "Polyethylene glycol recombinant endostatin",
"field": "Oncology and biomedicine",
"definition": "A formulation containing recombinant endostatin attached to polyethylene glycol (PEG), with potential anti-angiogenic and antineoplastic activities. Endostatin, a 20 kDa C-terminal proteolytic fragment of collagen XVIII, induces microvascular endothelial cell apoptosis and inhibits endothelial proliferation and angiogenesis, which may result in a reduction of tumor cell growth. Modification with PEG extends the circulation half-life of endostatin, improves stability and increases solubility in organic solvents.",
"synonyms": [
"M2ES"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/polyethylene-glycol-recombinant-endostatin/"
}
Record 13,437 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.